What do systematic reviews say?

Intrabronchial valves vs control

The review found no eligible studies for this question.

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Vapour ablation vs control

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 64 participants
  Moderate

Vapour ablation vs control

Vapour ablation showed no clear difference in mortality at end of compared with control (low certainty).

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  OR 2.82 [0.13, 61.06]
  1 study · 69 participants
  Low

Vapour ablation vs control

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 65 participants
  Low

Vapour ablation vs control

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 69 participants
  Moderate

AeriSeal vs control

The review found no eligible studies for this question.

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Vapour ablation vs control

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 69 participants
  Low

Vapour ablation vs control

Vapour ablation showed no clear difference in adverse events at end of compared with control (moderate certainty).

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  OR 3.86 [1, 14.97]
  1 study · 69 participants
  Moderate

Vapour ablation vs control

The review found no eligible studies for this question.

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

AeriSeal vs control

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 34 participants
  Low

AeriSeal vs control

AeriSeal probably leads to higher adverse events at end of compared with control (moderate certainty).

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  OR 3.71 [1.34, 10.24]
  1 study · 95 participants
  Moderate

AeriSeal vs control

The review found no eligible studies for this question.

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Airway bypass stents vs control

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 350 participants
  High

Airway bypass stents vs control

Airway bypass stents showed no clear difference in mortality at end of compared with control (moderate certainty).

• Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
  OR 0.76 [0.21, 2.77]
  1 study · 350 participants
  Moderate

Action plan vs usual care

Action plan showed no clear difference in hospitalisations for COPD/100 patient‐years (action plan + phone compared with usual care (moderate certainty).

• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
  Rate ratio 0.69 [0.47, 1.01]
  1 study · 743 participants
  Moderate

Action plan vs usual care

Action plan leads to lower hospitalisations and emergency visits for COPD/100 patient‐years… compared with usual care (high certainty).

• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
  Rate ratio 0.59 [0.44, 0.79]
  1 study · 743 participants
  High

Action plan vs usual care

Action plan probably leads to lower at least 1 hospital admission compared with usual care (moderate certainty).

• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
  Odds ratio 0.69 [0.49, 0.97]
  2 studies · 897 participants
  Moderate

Action plan vs usual care

Action plan showed no clear difference in mortality (all‐cause) compared with usual care (moderate certainty).

• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
  Odds ratio 0.88 [0.59, 1.31]
  4 studies · 1134 participants
  Moderate

Action plan vs usual care

• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 200 participants
  Moderate

Action plan vs usual care

• Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 943 participants
  Moderate